Lexicon Pharmaceuticals (LXRX) Deferred Taxes (2017)
Lexicon Pharmaceuticals' (LXRX) quarterly Deferred Taxes came in at -$4.0 million in Q4 2017, up 53.66% on a QoQ basis from -$8.7 million in Q1 2017.
Lexicon Pharmaceuticals (LXRX) Deferred Taxes (2017) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 1 years of Deferred Taxes data on file, last reported at -$4.0 million in Q4 2017.
- On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$4.0 million in Q4 2017; TTM through Sep 2018 was -$4.0 million, a 53.66% increase from a year earlier, with the FY2019 full-year figure at -$6.0 million, changed N/A from the prior year.
- Deferred Taxes for Q4 2017 stood at -$4.0 million, up from -$8.7 million in the prior quarter.
- Over the last five years, Deferred Taxes for LXRX reached as high as -$4.0 million in Q4 2017 and fell as low as -$8.7 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -4.01 Mn |
| Mar 31, 2017 | -8.65 Mn |